Affordable Cytology RBI's ClearPrep offers FDA-registered, reagent-based cytology slide preparation at lower cost, appealing to resource-constrained labs in developing regions (South America, Eastern Europe, Southeast Asia). Opportunity for distributors and government procurement, value proposition to price-sensitive clinics.

HPV Reflex Upsell ClearPrep enables reflex HPV 16/18 and other STD tests from the same sample, enabling labs to streamline workflows, reduce sample handling steps, and increase revenue per specimen.

Global Partnerships RBI already expanded into developing world markets; there is opportunity to scale via regional distributors, clinical labs, and public health programs in target regions such as South America, Eastern Europe, and Southeast Asia.

Screening Synergies Product usage extends to Fine Needle Aspiration, urine cytology for bladder cancer, and oral cancer screening, with ongoing development, offering cross-sell opportunities to oncology, urology, and pathology labs.

Strategic Partnerships As a nimble, specialty provider with an FDA-registered process and affordable pricing, RBI could partner with large diagnostic companies for OEM manufacturing, distribution, or integration into their cytology portfolios.